Lnc-ZEB1-AS1 enhances the expression of ZEB1 by elevating its promoter activity thus promoting the metastasis of HCC, and patients with ZEB1-AS1 hypomethylation are anticipated to have a high metastatic recurrence and poor survival outcomes [20]. The gene discussed is ZEB1; the disease is hepatocellular carcinoma.